NovoCure (NVCR) EBT Margin Growth (3y) (2017 - 2026)
NovoCure (NVCR) EBT Margin Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | -429.00 |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 574.00 |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 55.00 |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 764.00 |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 835.00 |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 598.00 |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 125.00 |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 631.00 |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 423.00 |
| 10 | NovoCure | 2.04 Bn | 1.60 Bn | 142.48 Mn | 3,598.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3,598.00 |
| Mar 31, 2026 | 202.00 |
| Dec 31, 2025 | 186.00 |
| Sep 30, 2025 | -8.00 |
| Jun 30, 2025 | -545.00 |
| Mar 31, 2025 | -1,772.00 |
| Dec 31, 2024 | -1,504.00 |
| Sep 30, 2024 | -603.00 |
| Jun 30, 2024 | -520.00 |
| Mar 31, 2024 | -2,082.00 |
| Dec 31, 2023 | -3,493.00 |
| Sep 30, 2023 | -4,620.00 |
| Jun 30, 2023 | -4,626.00 |
| Mar 31, 2023 | -3,610.00 |
| Dec 31, 2022 | -2,375.00 |
| Sep 30, 2022 | -1,929.00 |
| Jun 30, 2022 | -1,653.00 |
| Mar 31, 2022 | 975.00 |
| Dec 31, 2021 | -366.00 |
| Sep 30, 2021 | 392.00 |